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Purpose
Interest is growing in regenerative medicine on validated animal models. A micro-CT
approach to quantitate bone regeneration in large lesions on rat femurs is presented here.
Bone pathologies involve a growing number of people. Traditional therapeutic
approaches use bone transplants or prosthesis implants but many alternative and more
efficient therapies have been developed, especially in diseases with significant loss of
substance or in subjects with production deficit of the bone callus. Biomedical engineering
has long been trying to produce new biomimetic materials (biological or synthetic
scaffolds) which, associated or not with cellular therapy, would be able to stimulate bone
repair [1]-[3].
With newly designed scaffolds, most of the challenges of critical size bone defects have
been resolved in-vitro [4], and in some cases in animal models as well [4]-[5]. However,
important challenges still need to be met before these technologies can be fully converted
from the bench to the bedside. These technological and biological advancements need
to be turned into mass production of affordable products to be used worldwide.
Methods and Materials
Innovative therapeutic methods need to be validated in animal models for efficacy and
safety. An experimental model has been implemented on small animals to study the
development of the bone repair process in vivo. A variable geometry micro-CT scanner
with rotating gantry, as described below, was used for all measurements.
1) Lesion model
A 5 mm bone lesion (drill injury) with medullary canal involvement was performed in the
lateral cortex on both rat femurs (Fig. 1 on page 4, top-left). In the same animal,
one lesion was treated, while the contralateral was left untreated (control). Scaffolds or
other devices may be introduced in the lesion site aimed at intervening on the repair
process. All the surgical procedures were made by specialized veterinary staff, under
general anesthesia and in agreement with national (Italian Legislative Decree 116/92)
and European guidelines (DIRECTIVE 2010/63/UE). The advantage of a bilateral large
diamater drill-hole lesion with respect to a complete fracture is that the animals does not
require immobilization of the lower limbs.
2) Micro-CT scanner
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The Xalt scanner (X-ray AnimaL Tomograph, Fig. 2 on page 5) is a rotating gantry,
cone-beam µCT for small animals [6]. It was built in the framework of a collaboration
between the Institute of Clinical Physiology (IFC-CNR) and the Functional Imaging and
Instrumentation Group (FIIG) of the Department of Physics "E. Fermi", University of Pisa.
The Xalt scanner allows to select the geometric magnification to set a trade-off between
spatial resolution and field-of-view (FoV). It is equipped with a W-anode microfocus X-
ray source with accelerating potential in the range of 20-50 kV, and with a 10x5 cm2
flat-panel CMOS detector with Gadox scintillator. For a single (non-helical) tomographic
scan, the maximum transaxial FoV size is 80 mm in diameter for the 'Large FoV' (LF)
setup, with a isotropic voxel size of 40 µm; the minimum voxel size is 18.4 µm in the
'High Resolution' (HR) setup. The minimum acquisition time is 43 s for fast, low-dose
in-vivo scans, and can be as high as 4 hours for ex-vivo, low-contrast high resolution
studies. Typical scan times are 2-10 min for in-vivo imaging of mice and rats at 40-80 µm
resolution, and 10-90 min for ex-vivo scans of organs and biopsies at 18-40 µm resolution.
3) Imaging protocol
In-vivo longitudinal micro-CT scans were performed to monitor relative lesion changes
under diverse treatments (Fig. 1 on page 4, top-right, and Fig. 3 on page 6, left).
Due to lesion sites and extension, legs had to be scanned in natural position, although
this has limited the spatial resolution for both geometric and dose considerations. In
fact, the 6-7 cm cross section of the rat body at the lower limbs level required the use
of the LF setup (8 cm transaxial FOV), with resolution limit of 40 µm [6]. Due to the
presence of radiosensitive organs in the Field of Measurement (FOM), such as bladder
and gonads, in order to reduce the cumulative dose over the whole follow-up period (3-5
scans over 30-90 days) we have performed the in-vivo scans at the isotropic resolution of
80 µm. During the micro-CT scan, the rats were anesthesized via intraperitoneal injection
of ketamine and, if necessary, anesthesia was mantained by inhalation of isofluorane.
Care has been taken to ensure proper immobilization of the legs and pelvis during the
acquisition time, in order to avoid motion artifacts. At the study end and prior to histology,
each animal was euthanised and both femurs were excised (Fig. 1 on page 4, bottom-
right); then, a final scan was performed in the HR setup on each explanted femur inserted
into a test tube, placed at the tip of the animal bed. (Fig. 1 on page 4, bottom-center,
and Fig. 3 on page 6, right).
4) Image analysis
For each scan, a volume of interest (VOI) comprising the whole lesion (7 mm long,
centered at the hole in the mid-diaphisis, Fig. 4 on page 6) was selected. The analysis
was performed using the BoneJ plugin [7] of the ImageJ software [8].
The following parameters were measured in each VOI:
• bone volume (BV) (in-vivo and ex-vivo);
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• mean and standard deviation of cortical thickness (Ct.Th.Mean, Ct.Th.SD)
(in-vivo and ex-vivo);
• bone surface (BS) (ex-vivo);
• surface/volume ratio (BS/BV) (ex-vivo);
and, if relevant,
• size of the residual hole (if present) (Dx, Dy, Fig. 5 on page 7) (ex-vivo);
• residual depth of the groove at the site of action (Dp, negative values 
indicate a surplus, Fig. 5 on page 7) (ex-vivo);
• foramen submillimetre in presence of callus (1: yes 0: no) (ex-vivo)
• presence of cap-like callus (1: yes 0: no) (in-vivo and ex-vivo)
High values of BS/BV indicate high porosity (not very compact bone).
High values of Ct.Th.SD denote a high non-uniformity of the bone in VOI.
Images for this section:
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Fig. 1: Large lesion model and study protocol on rat femurs. See text for details.
Page 6 of 14
Fig. 2: The Xalt micro-CT scanner at IFC-CNR. The inset shows the gantry and the
mechanisms by which the geometry can be changed to set the proper resolution and
field of measurement (FOM).
Fig. 3: Due to the lesion site and extension, the in-vivo imaging required the acquisition
of the whole lower abdomed at medium resolution and low dose (left). After the femur
excision, it was possible to place it on a test tube for high resolution imaging (right). See
text for details.
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Fig. 4: The progression of bone repair as studied with longitudinal micro-CT imaging. For
comparison, a final ex-vivo scan of the same femur is reported. The red lines delimit the
volume of interest (VOI) selected for the image analysis.
Fig. 5: In case of partial healing, a residual hole with communicating foramen is observed
at the therapy endpoint (left). At right, a color-coded local thickness map [7] of the lesion
VOI is shown. The values in the calibration bar are in mm. A partial healing will involve a
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large fraction of non-compact, spongious-like bone that lead to a high etereogeneity (i.e.,
high standard deviation) of Ct.Th in the VOI.
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Results
1) In-vivo imaging
The average entrance surface dose (ESD) in the scanned volume was 100 mGy at 80
µm voxel (3 min full-scan, 50 kV, 1 mm Al filtration, 120 mAs total). In few cases, a higher
resolution scan (40 µm voxel) was done, with a ESD of 300 mGy (7 min full-scan, 50
kV, 1 mm Al filtration, 290 mAs total). Doses were derived from phantom measurements
with thermoluminescence dosimetry (TLD). Bone volume fraction (BV/TV) and average
cortical thickness (Ct.Th) can be measured at this resolution, allowing a semi-quantitative
assessment of short-term callus evolution and lesion healing following the use of different
therapies (Fig. 4 on page 9).
The specific size of the VOI helped to ensure reproducibility of the analysis between
different scans on the same femur; nevertheless, the natural growth of the intact
bone inside the VOI may have decreased the sensitivity of the measurement. Further
optimization will be necessary to reduce the VOI size and restrict it to the lesion site, by
keeping the same degree of inter-scan reproducibility.
2) Ex-vivo imaging
The scanner isotropic resolution of 18 µm (HR setup) allowed the full quantification
of three-dimensional (3D) bone morphometry ex-vivo, in term of BV, BS, BS/BV,
Ct.Th.Mean and Ct.Th.SD. Long-term bone quality is quantitatively evaluated using this
information. An example of partial healing after 90 days from the treatment is shown in
Fig. 5 on page 10, with evidence of both residual hole and foramen. The presence of
non-compact, spongious-like bone in the VOI is another marker of partial healing, causing
an increase of Ct.Th.SD (Fig. 5 on page 10, right).
Images for this section:
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Fig. 4: The progression of bone repair as studied with longitudinal micro-CT imaging. For
comparison, a final ex-vivo scan of the same femur is reported. The red lines delimit the
volume of interest (VOI) selected for the image analysis.
Fig. 5: In case of partial healing, a residual hole with communicating foramen is observed
at the therapy endpoint (left). At right, a color-coded local thickness map [7] of the lesion
VOI is shown. The values in the calibration bar are in mm. A partial healing will involve a
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large fraction of non-compact, spongious-like bone that lead to a high etereogeneity (i.e.,
high standard deviation) of Ct.Th in the VOI.
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Conclusion
Bone pathology simulation with loss of substance in both femurs provided a way to have
reliable controls in each animal. The lesion was well tolerated in all animals; this and the
low dose in-vivo due the micro-CT scans allowed longitudinal studies over long follow-
up periods (up to 3 months).
Quantitative evaluation of large lesion healing in rat femurs is challenging. Using our
variable resolution micro-CT, we demonstrated that this is feasible by merging information
of in-vivo and ex-vivo scans, thus obtaining a semi-quantitative assessment of short-term
callus evolution together with a quantitative evaluation of long-term bone quality.
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